NPCE Stock Summary and Trading Ideas (Neuropace | NASDAQ:NPCE)

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

What symbol and exchange does Neuropace shares trade?

Neuropace trades on the NASDAQ stock market under the symbol NPCE.

What is Neuropace stock price doing today?

As of June 12, 2026, NPCE stock price declined to $15.64 with 83,181 million shares trading.

What is Neuropace's Beta?

NPCE has a beta of 0.82, meaning it tends to be less sensitive to market movements. NPCE has a correlation of 0.03 to the broad based SPY ETF.

How much is Neuropace worth?

NPCE has a market cap of $533.23 million. This is considered a Small Cap stock.

How much money does Neuropace make?

Last quarter Neuropace reported $22 million in Revenue and -$.20 earnings per share. This beat revenue expectation by $423,776 and exceeded earnings estimates by $.02.

What is the highest and lowest price Neuropace traded in the last 3 year period?

In the last 3 years, NPCE traded as high as $19.60 and as low as $3.91.

What are the top ETFs holding Neuropace?

The top ETF exchange traded funds that NPCE belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

Is Neuropace (NPCE) a good investment?

NPCE has outperformed the market in the last year with a return of +39.3%, while the SPY ETF gained +24.1%. However, in the most recent history, NPCE shares have underperformed the stock market with its stock returning +10.8% in the last 3 month period and -5.4% for the last 2 week period, while SPY has returned +11.6% and -1.9%, respectively.

What are the support and resistance levels for Neuropace (NPCE)?

NPCE support price is $15.32 and resistance is $16.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NPCE shares will trade within this expected range on the day.